This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, G. A. Articles by King, D. S. Search for Related Content PubMed PubMed Citation Articles by Brown, G. A. Articles by King, D. S.

Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men¹

Exercise Biochemistry Laboratory (G.A.B., E.R.M., M.L.K., W.D.F., D.A.J., D.S.K.), Department of Health and Human Performance, Iowa State University, Ames Iowa 50011; and Human Performance Laboratory (M.D.V.), South Dakota State University Department of HPER, Brookings, South Dakota

Address all correspondence and requests for reprints to: Douglas S. King, Ph.D., Department of Health and Human Performance, 248 Forker Building, Iowa State University, Ames, Iowa 50011. E-mail: dsking{at}iastate.edu

In young men, chronic ingestion of 100 mg androstenedione (ASD), three times per day, does not increase serum total testosterone but does increase serum estrogen and ASD concentrations. We investigated the effects of ASD ingestion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned manner, subjects consumed 100 mg ASD three times daily (n = 28), or placebo (n = 27) for 28 days. Serum ASD , dihydrotestosterone (DHT), free and total testosterone, estradiol, prostate-specific antigen (PSA), and lipid concentrations were measured at week 0 and each week throughout the supplementation period. Serum total testosterone and PSA concentrations did not change with supplementation. Elevated serum concentrations of ASD (300%), free testosterone (45%), DHT (83%), and estradiol (68%) were observed during weeks 1–4 in ASD (P < 0.05). There was no relationship between age and changes in serum ASD (r² = 0.024), free testosterone (r² = 0.00), or estradiol (r² = 0.029) concentrations with ASD, whereas the serum DHT response to ASD ingestion was related to age (r² = 0.244; P < 0.05). Serum concentrations of high-density lipoprotein cholesterol were decreased by 10% during the supplementation period (P < 0.05). These results suggest that the ingestion of 100 mg ASD , three times per day, does not increase serum total testosterone or PSA concentrations but does elicit increases in ASD, free testosterone, estradiol, and DHT and decreases serum high-density lipoprotein cholesterol concentrations.

This article has been cited by other articles:

				Y. Schrader, M. Thevis, and W. Schanzer QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY Drug Metab. Dispos., August 1, 2006; 34(8): 1328 - 1335. [Abstract] [Full Text] [PDF]

				R. Jasuja, P. Ramaraj, R. P. Mac, A. B. Singh, T. W. Storer, J. Artaza, A. Miller, R. Singh, W. E. Taylor, M. L. Lee, et al. {Delta}-4-Androstene-3,17-Dione Binds Androgen Receptor, Promotes Myogenesis in Vitro, and Increases Serum Testosterone Levels, Fat-Free Mass, and Muscle Strength in Hypogonadal Men J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 855 - 863. [Abstract] [Full Text] [PDF]

				T. Bassindale, D. A. Cowan, S. Dale, A. J. Hutt, A. R. Leeds, M. J. Wheeler, and A. T. Kicman Effects of Oral Administration of Androstenedione on Plasma Androgens in Young Women Using Hormonal Contraception J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6030 - 6038. [Abstract] [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, and D. S. King Urinary Excretion of Steroid Metabolites after Chronic Androstenedione Ingestion J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6235 - 6238. [Abstract] [Full Text] [PDF]

				M. L. Kohut, J. R. Thompson, J. Campbell, G. A. Brown, M. D. Vukovich, D. A. Jackson, and D. S. King Ingestion of a Dietary Supplement Containing Dehydroepiandrosterone (DHEA) and Androstenedione Has Minimal Effect on Immune Function in Middle-Aged Men J. Am. Coll. Nutr., October 1, 2003; 22(5): 363 - 371. [Abstract] [Full Text] [PDF]

				S G Beckham and C P Earnest Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men Br. J. Sports Med., June 1, 2003; 37(3): 212 - 218. [Abstract] [Full Text] [PDF]

				A. T. Kicman, T. Bassindale, D. A. Cowan, S. Dale, A. J. Hutt, and A. R. Leeds Effect of Androstenedione Ingestion on Plasma Testosterone in Young Women; a Dietary Supplement with Potential Health Risks Clin. Chem., January 1, 2003; 49(1): 167 - 169. [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine and Lipid Responses to Chronic Androstenediol-Herbal Supplementation in 30 to 58 Year Old Men J. Am. Coll. Nutr., October 1, 2002; 20(5): 520 - 528. [Abstract] [Full Text] [PDF]

				G. A. Brown, E. R. Martini, B. S. Roberts, M. D. Vukovich, and D. S. King Acute hormonal response to sublingual androstenediol intake in young men J Appl Physiol, January 1, 2002; 92(1): 142 - 146. [Abstract] [Full Text] [PDF]

				W. Rosner LETTER TO THE EDITOR: An Extraordinarily Inaccurate Assay for Free Testosterone Is Still with Us J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2903 - 2903. [Full Text] [PDF]